search
Back to results

Effects of a Weight Loss Program in People With Hip Osteoarthritis (ECHO)

Primary Purpose

Hip Osteoarthritis, Overweight and Obesity

Status
Active
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Weight loss
Exercise
Sponsored by
University of Melbourne
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hip Osteoarthritis focused on measuring Osteoarthritis, Osteoarthritis, hip, Obesity, Overweight, Weight loss, Arthritis, Joint diseases, Musculoskeletal diseases, Telehealth

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • American College of Rheumatology classification criteria with pain in the groin or hip region on most days of the past month and femoral or acetabular osteophytes and joint space narrowing (superior, axial and/ or medial) on x-ray;
  • aged 50 years or older;
  • report history of hip pain ≥ 3months;
  • report an average pain score of at least 4 on an 11-point numeric rating scale (anchored at 0=no pain, 10=worst pain imaginable) over the previous week;
  • access to a device with internet connection;
  • have a BMI >27 kg/m2;
  • willing and able give informed consent and participate fully in the interventions and assessment procedures;
  • have ability to weigh themselves (e.g. access to scales);
  • pass the Exercise and Sports Science Australia stage 1 adult pre-exercise screening system or obtain general practitioner clearance for participation in the study.

Exclusion Criteria:

  • weight >150 kgs (due to the added complexities of additional nutritional requirements for individuals above this weight);
  • inability to speak and read English;
  • on waiting list for/planning back/lower limb surgery or bariatric surgery in next 12 months;
  • previous arthroplasty on affected hip;
  • recent hip surgery on affected hip (past 6 months);
  • self-reported inflammatory arthritis (e.g. rheumatoid arthritis);
  • weight loss of > 2 kg over the previous 3 months;
  • already actively trying to lose weight by any of the following mechanisms:

    1. using meal replacements for weight loss
    2. being a member of a commercial weight loss program (e.g. weight watchers)
    3. receiving support from another health care professional for weight loss
    4. using any drugs prescribed to aid in weight loss
    5. using structured meal programs for weight loss such as 'Lite n' Easy'
  • unable to undertake ketogenic VLCD without closer medical supervision including self-reported:

    1. diagnosis of Type 1 diabetes
    2. Type 2 diabetes requiring insulin or other medication apart from metformin
    3. warfarin use
    4. stroke or cardiac event in previous 6 months
    5. unstable cardiovascular condition
    6. fluid intake restriction
    7. renal (kidney) problems (unless clearance is obtained from GP, including GP confirmation that estimated glomerular filtration rate >30 mL/min/1.73m2)
  • any neurological condition affecting lower limbs;
  • pregnancy or planned pregnancy
  • vegan dietary requirements due to complexity of delivering a nutritionally complete diet within the ketogenic diet regime.

Sites / Locations

  • University of Melbourne

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Weight loss and exercise

Exercise only

Arm Description

In addition to the physiotherapist-prescribed exercise program, participants in the weight loss and exercise group will also undergo six consultations with a dietitian. They will undergo a ketogenic very low-calorie diet (VLCD) including meal replacements, with an intensive weight loss phase and weight maintenance phase. The exercise component will be the same as that provided for the exercise only comparator. All dietitian and physiotherapy consultations will be delivered online by video-conference platform.

Participants will undergo five consultations (30-45 minutes) with a physiotherapist over 6 months for prescription of a home-based strengthening exercise program and physical activity plan (to be conducted independently at home), as well as OA education. All consultations will be conducted remotely via video-conference.

Outcomes

Primary Outcome Measures

Severity of hip pain
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week. Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.

Secondary Outcome Measures

Severity of hip pain
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week. Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.
Body weight
Measured on home scales and self-reported in kilograms. The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
Body weight
Measured on home scales and self-reported in kilograms. The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
Body Mass Index (BMI)
Calculated from height and weight, in Kg/m2
Body Mass Index (BMI)
Calculated from height and weight, in Kg/m2
Total body fat mass
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass
Hip pain
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units). Expressed as percentage relative to number of participants allocated to each group.
Hip pain
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units). Expressed as percentage relative to number of participants allocated to each group.
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain. Ranges from 0 to 20 and normalised to 0 - 100 scale. Higher scores indicate less pain.
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain. Ranges from 0 to 20 and normalised to 0 - 100 scale. Higher scores indicate less pain.
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction. Ranges from 0 to 68 and normalised to 0 - 100 scale. Higher scores indicate less dysfunction.
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction. Ranges from 0 to 68 and normalised to 0 - 100 scale. Higher scores indicate less dysfunction.
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme. Ranges from 0 to 16 and normalised to 0 - 100 scale. Higher scores indicate better quality of life.
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme. Ranges from 0 to 16 and normalised to 0 - 100 scale. Higher scores indicate better quality of life.
Quality of life (AQoL-8D)
Scored from 35 questions regarding health-related quality of life in the last week. Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
Quality of life (AQoL-8D)
Scored from 35 questions regarding health-related quality of life in the last week. Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
Global rating of change in physical activity
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
Global rating of change in physical activity
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
Global rating of overall change in hip problem
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
Global rating of overall change in hip problem
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
Visceral fat mass
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass

Full Information

First Posted
March 28, 2021
Last Updated
March 8, 2023
Sponsor
University of Melbourne
search

1. Study Identification

Unique Protocol Identification Number
NCT04825483
Brief Title
Effects of a Weight Loss Program in People With Hip Osteoarthritis
Acronym
ECHO
Official Title
Effects of a Weight Loss Program in People With Hip Osteoarthritis: a Randomised Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
June 16, 2021 (Actual)
Primary Completion Date
July 2023 (Anticipated)
Study Completion Date
January 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Melbourne

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This randomised controlled trial will compare the effects of a weight loss and exercise program to exercise only on clinical outcomes in 100 people with hip osteoarthritis (OA) and overweight or obesity. The primary aim is to find out whether a weight loss and exercise program will improve hip pain more than an exercise program alone at 6 months follow-up
Detailed Description
Clinical guidelines recommend exercise as the core treatment for symptoms, but provide conflicting recommendations about weight loss for people with hip OA. Irrefutable health benefits are associated with weight loss for those with overweight or obesity, but it remains uncertain whether weight loss in addition to exercise and regular physical activity is superior to exercise alone for hip OA symptoms. This study is a randomized controlled trial for which the aim is to determine whether a weight loss and exercise program improves hip pain more than an exercise program alone at 6 months among people with hip OA who have overweight or obesity. A total of 100 people with hip osteoarthritis and overweight or obesity will be recruited from the community. Participants will be assessed for eligibility, including review of a hip x-ray. They will be enrolled into the study following informed consent and completion of baseline questionnaires and laboratory-based measures. Each participant will be randomly allocated to receive either: a) weight loss plus exercise program or; b) exercise program alone, over 6 months. The randomisation schedule will be prepared by a biostatistician (permuted block sizes 2 to 6) stratified by site and sex. Participants allocated to the exercise group will be randomly allocated to a physiotherapist. Participants allocated to the exercise plus weight loss group will be randomly allocated to one of the same physiotherapists as the exercise group, and to a dietitian. The schedule will be stored on a password-protected platform at the University of Melbourne and maintained by a researcher not involved in either participant recruitment or administration of outcome measures. Group allocation will be revealed after completion of baseline measures and randomisation. Dietitians will complete training in best-practice OA management (half day workshop led by investigators), motivational interviewing skills (2-day training course), weight management (the ketogenic very low calorie diet) and trial procedures. Physiotherapists will be trained in trial procedures, best practice OA management, strengthening and physical activity program, behaviour change techniques to promote adherence and resources for use in the program. Study participants in both groups will attend 5 individual physiotherapy consultations via video-conference over 6 months and will undertake a home-based lower limb muscle strengthening exercise and physical activity program. Those in the weight loss and exercise group will also undertake a ketogenic very low calorie diet (VLCD), which has been demonstrated as a safe and effective means of achieving rapid weight loss in the adult population with overweight/obesity. They will receive meal replacements (maximum 2 per day) for up to 6 months as well as educational resources. A biostatistician will analyse blinded data. The statistical method will be outlined in a Statistical Analysis Plan.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hip Osteoarthritis, Overweight and Obesity
Keywords
Osteoarthritis, Osteoarthritis, hip, Obesity, Overweight, Weight loss, Arthritis, Joint diseases, Musculoskeletal diseases, Telehealth

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
A superiority, 2-group, parallel randomised controlled trial
Masking
Investigator
Masking Description
Participants will not be informed about the study hypotheses, until the study is completed, at which time they will be provided a lay summary of study findings. However, the components of each treatment arm will be disclosed during recruitment, allowing us to test the interventions in a way whereby potential participants are fully informed about the nature of the components before deciding whether to participate. As the primary and some of the secondary outcomes are participant-reported, participants are also the outcome assessors and are unblinded. Physiotherapists and dietitians will not be blinded to group allocation or study hypothesis. Staff collecting the secondary outcome body composition data will be blinded to group allocation. Research staff administering and entering the participant-reported data will be blinded. Statistical analyses will be performed blinded.
Allocation
Randomized
Enrollment
101 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Weight loss and exercise
Arm Type
Experimental
Arm Description
In addition to the physiotherapist-prescribed exercise program, participants in the weight loss and exercise group will also undergo six consultations with a dietitian. They will undergo a ketogenic very low-calorie diet (VLCD) including meal replacements, with an intensive weight loss phase and weight maintenance phase. The exercise component will be the same as that provided for the exercise only comparator. All dietitian and physiotherapy consultations will be delivered online by video-conference platform.
Arm Title
Exercise only
Arm Type
Active Comparator
Arm Description
Participants will undergo five consultations (30-45 minutes) with a physiotherapist over 6 months for prescription of a home-based strengthening exercise program and physical activity plan (to be conducted independently at home), as well as OA education. All consultations will be conducted remotely via video-conference.
Intervention Type
Other
Intervention Name(s)
Weight loss
Intervention Description
Participants will receive resources to support the weight loss program including a recipe book, activities book and "how-to guide". The diet program comprises two phases: 1) intensive weight loss through a ketogenic Very Low Calorie Diet (VLCD), including meal replacements for two meals/day, and 2) transition from ketogenic VLCD onto a longer-term eating plan for weight maintenance. Meal replacements will be provided free of charge for up to 6 months. Participants will be encouraged to lose at least 10% body weight.
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
Participants will receive resources to facilitate the physiotherapy management plan, including information about the video-conference platform, osteoarthritis information, an exercise plan/log book and a booklet of possible exercises. The physiotherapist consultations include a structured, progressive exercise and physical activity plan. Participants will be given exercise resistance bands and a ankle weight for home exercises. Physiotherapists will choose from a list of exercises, aiming to prescribe 5-6 at once. Intensity is determined using a modified Rating of Perceived Exertion (RPE) scale, where it should feel "hard" to "very hard" to perform a full set of each exercises. Participants are encouraged to complete exercises three times per week. Physiotherapists encourage the participant to increase their general and incidental levels of physical/aerobic activity based on their individual needs and goals, as well as their current level of activity.
Primary Outcome Measure Information:
Title
Severity of hip pain
Description
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week. Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.
Time Frame
Change between baseline and 6 months post-randomisation
Secondary Outcome Measure Information:
Title
Severity of hip pain
Description
Scored on an 11-point Numeric Rating Scale for average hip pain in the last week. Ranges from 0 to 10; where 0=no pain and 10=worst pain possible.
Time Frame
Change between baseline and 12 months post-randomisation
Title
Body weight
Description
Measured on home scales and self-reported in kilograms. The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
Time Frame
Change between baseline and 6 months post-randomisation
Title
Body weight
Description
Measured on home scales and self-reported in kilograms. The percentage of body weight change (baseline-follow up/baseline x100%) will be calculated .
Time Frame
Change between baseline and 12 months post-randomisation
Title
Body Mass Index (BMI)
Description
Calculated from height and weight, in Kg/m2
Time Frame
Change between baseline and 6 months post-randomisation
Title
Body Mass Index (BMI)
Description
Calculated from height and weight, in Kg/m2
Time Frame
Change between baseline and 12 months post-randomisation
Title
Total body fat mass
Description
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass
Time Frame
Change between baseline and 6 months post-randomisation
Title
Hip pain
Description
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units). Expressed as percentage relative to number of participants allocated to each group.
Time Frame
6 months post-randomisation
Title
Hip pain
Description
Proportion of participants who meet or exceed the minimal clinical important difference in Numerical Rating Scale for pain (1.8 units). Expressed as percentage relative to number of participants allocated to each group.
Time Frame
12 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Description
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain. Ranges from 0 to 20 and normalised to 0 - 100 scale. Higher scores indicate less pain.
Time Frame
Change between baseline and 6 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Pain Subscale
Description
Scored using 10 questions regarding hip pain in the last week, with Likert response options ranging from no pain to extreme pain. Ranges from 0 to 20 and normalised to 0 - 100 scale. Higher scores indicate less pain.
Time Frame
Change between baseline and 12 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Description
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction. Ranges from 0 to 68 and normalised to 0 - 100 scale. Higher scores indicate less dysfunction.
Time Frame
Change between baseline and 6 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Activities of daily living subscale
Description
Scored using 17 questions regarding hip function in the last week, with Likert response options ranging from no dysfunction to extreme dysfunction. Ranges from 0 to 68 and normalised to 0 - 100 scale. Higher scores indicate less dysfunction.
Time Frame
Change between baseline and 12 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Description
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme. Ranges from 0 to 16 and normalised to 0 - 100 scale. Higher scores indicate better quality of life.
Time Frame
Change between baseline and 6 months post-randomisation
Title
Hip Osteoarthritis Outcome Scale (HOOS) Quality of Life Subscale
Description
Scored using 4 questions regarding quality of life in the last week, with Likert response options ranging from none to extreme. Ranges from 0 to 16 and normalised to 0 - 100 scale. Higher scores indicate better quality of life.
Time Frame
Change between baseline and 12 months post-randomisation
Title
Quality of life (AQoL-8D)
Description
Scored from 35 questions regarding health-related quality of life in the last week. Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
Time Frame
Change between baseline and 6 months post-randomisation
Title
Quality of life (AQoL-8D)
Description
Scored from 35 questions regarding health-related quality of life in the last week. Ranges from -0.04 to 1.00; higher scores indicate better quality of life.
Time Frame
Change between baseline and 12 months post-randomisation
Title
Global rating of change in physical activity
Description
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
Time Frame
6 months post-randomisation
Title
Global rating of change in physical activity
Description
Scored using a 7-point global rating of change Likert scale with response options ranging from "much less" to "much more" when compared to baseline.
Time Frame
12 months post-randomisation
Title
Global rating of overall change in hip problem
Description
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
Time Frame
6 months post-randomisation
Title
Global rating of overall change in hip problem
Description
Scored using a 7-point global rating of change Likert scale with response options ranging from "much worse" to "much better" when compared to baseline.
Time Frame
12 months post-randomisation
Title
Visceral fat mass
Description
Measured using dual energy x-ray absorptiometry and reported in grams and % of total body mass
Time Frame
Change between baseline and 6 months post-randomisation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: American College of Rheumatology classification criteria with pain in the groin or hip region on most days of the past month and femoral or acetabular osteophytes and joint space narrowing (superior, axial and/ or medial) on x-ray; aged 50 years or older; report history of hip pain ≥ 3months; report an average pain score of at least 4 on an 11-point numeric rating scale (anchored at 0=no pain, 10=worst pain imaginable) over the previous week; access to a device with internet connection; have a BMI >27 kg/m2; willing and able give informed consent and participate fully in the interventions and assessment procedures; have ability to weigh themselves (e.g. access to scales); pass the Exercise and Sports Science Australia stage 1 adult pre-exercise screening system or obtain general practitioner clearance for participation in the study. Exclusion Criteria: weight >150 kgs (due to the added complexities of additional nutritional requirements for individuals above this weight); inability to speak and read English; on waiting list for/planning back/lower limb surgery or bariatric surgery in next 12 months; previous arthroplasty on affected hip; recent hip surgery on affected hip (past 6 months); self-reported inflammatory arthritis (e.g. rheumatoid arthritis); weight loss of > 2 kg over the previous 3 months; already actively trying to lose weight by any of the following mechanisms: using meal replacements for weight loss being a member of a commercial weight loss program (e.g. weight watchers) receiving support from another health care professional for weight loss using any drugs prescribed to aid in weight loss using structured meal programs for weight loss such as 'Lite n' Easy' unable to undertake ketogenic VLCD without closer medical supervision including self-reported: diagnosis of Type 1 diabetes Type 2 diabetes requiring insulin or other medication apart from metformin warfarin use stroke or cardiac event in previous 6 months unstable cardiovascular condition fluid intake restriction renal (kidney) problems (unless clearance is obtained from GP, including GP confirmation that estimated glomerular filtration rate >30 mL/min/1.73m2) any neurological condition affecting lower limbs; pregnancy or planned pregnancy vegan dietary requirements due to complexity of delivering a nutritionally complete diet within the ketogenic diet regime.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kim Bennell, PhD
Organizational Affiliation
University of Melbourne
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Melbourne
City
Carlton
State/Province
Victoria
ZIP/Postal Code
3010
Country
Australia

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
PD can be shared
IPD Sharing Time Frame
Available upon publication of results
IPD Sharing Access Criteria
Upon reasonable request
Citations:
PubMed Identifier
35248012
Citation
Hall M, Hinman RS, Knox G, Spiers L, Sumithran P, Murphy NJ, McManus F, Lamb KE, Cicuittini F, Hunter DJ, Messier SP, Bennell KL. Effects of adding a diet intervention to exercise on hip osteoarthritis pain: protocol for the ECHO randomized controlled trial. BMC Musculoskelet Disord. 2022 Mar 5;23(1):215. doi: 10.1186/s12891-022-05128-9.
Results Reference
derived

Learn more about this trial

Effects of a Weight Loss Program in People With Hip Osteoarthritis

We'll reach out to this number within 24 hrs